IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00961-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Min Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dong C…. Hauptthemen laut MEDLINE: Paclitaxel, Triple Negative Breast Neoplasms, Protein Serine-Threonine Kinases, Endoribonucleases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, The Science and Technology Commission of Shanghai Municipality, ECNU Construction Fund of Innovation and Entrepreneurship Laboratory.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dong Chuan Rd, Shanghai, 200241, China.
- Shanghai World Foreign Language Academy, Shanghai, 200030, China.
- Department of Reproductive Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, 272000, China.
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dong Chuan Rd, Shanghai, 200241, China. zfyi@bio.ecnu.edu.cn.
Förderung
- National Natural Science Foundation of China
- The Science and Technology Commission of Shanghai Municipality
- ECNU Construction Fund of Innovation and Entrepreneurship Laboratory
- Shanghai Rising-Star Program
Zitieren
APA
Wu, M., Zhang, L., Pi, L., Liu, L., Wang, S., Wu, Y., Pan, H., Liu, M., & Yi, Z. (2024). IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells. Cellular Oncology. https://doi.org/10.1007/s13402-024-00961-7
Vancouver
Wu M, Zhang L, Pi L, Liu L, Wang S, Wu Y, et al. IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells. Cellular Oncology. 2024. doi:10.1007/s13402-024-00961-7
BibTeX
@article{Wu2024,
author = {Wu, Min and Zhang, Lin and Pi, Lifu and Liu, Layang and Wang, Siyu and Wu, Yujie and Pan, Hongli and Liu, Mingyao and Yi, Zhengfang},
title = {IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00961-7}
}
EUVIMED